Our Blog

The Diagnostics Revolution has Arrived: Is Your Marketing Team Ready?

Kate Clark & Martha Townsend
July 15, 2019

There is no question about it, the diagnostic space is transforming to a more patient-centric focus. Personalized medicine is a reality, thanks to the more than 35 companion diagnostic tests that are now commercially available. Customized NGS biomarker panels are changing the way that patients are both diagnosed and treated. With this transformative shift in… Read more »

USCAP 2019 – Personalizing Pathology, Reflections from Market Ready Rx

Kate Clark, Managing Director, Market Ready Rx
May 3, 2019

“Unlocking your Ingenuity” was the brilliantly appointed theme for the 2019 USCAP Annual Meeting that seemed to reverberate off the walls of the Gaylord Convention Center in Maryland in March. It occurred to me that this Tony Robbins-esque theme could be applied to the field of personalized medicine as a whole.   The direct patient focus… Read more »

The Times They Are A Changin’ – 2018 Commercial Roundup

Martha Townsend
December 21, 2018

2018 Market Ready Rx Roundup This year was clearly a turnaround year for the In Vitro Diagnostic industry, providing proof that all diagnostic products in the future must drive individual patient decisions. From the timely NGS coverage decision in March, making reimbursement available for all cancer patients, to PD-L1 testing to guide Immuno-Oncology treatments, personalized… Read more »

Delivering Kick-Ass Marketing with a Passion

Kate Clark
June 29, 2018

Kick-ass \ ˈkik-ˌas \ (adjective): strikingly or overwhelmingly powerful or effective. Passion \ ˈpa-shən \ (noun): a strong liking or desire for or devotion to some activity, object, or concept. Marketing \ ˈmär-kə-tiŋ \ (noun): an aggregate of functions involved in moving goods from producer to consumer. You see where we’re going here, right? Market… Read more »

Reflections from USCAP 2018 in Vancouver – an Industry Recap

Martha Townsend
May 22, 2018

The diverse city of Vancouver set the perfect tone for learning and collaborating at the 2018 USCAP meeting; a welcoming city, rich with breathtaking vistas, great Canadian hospitality and fantastic international cuisine. Having attended USCAP for more than 15 years, I was impressed by the meeting’s progress; evolving beyond dry lectures with morphology slide reviews… Read more »

Embracing Emotions in Medical Marketing

Guest blog by Glenn Sagon, Sagon-Phior with Introduction by Martha Townsend, Market Ready Rx
May 12, 2018

Does emotional marketing have a place in the serious business of medical diagnostic marketing? I would argue that with today’s edgy genomic product messages overwhelming our customers, all our marketing communication needs to connect emotionally with our customers now more than ever. In a world of social media where our relationships with strangers feel real,… Read more »

Elevating Marketing Collaborations Using a Powerful Emotional Intelligence Tool

Guest blogger- Mariaelena Welch PCC, CEQC a Market Ready Rx advisor and coach
October 23, 2017

Collaboration. A buzzy word these days. Buzz-worthy for sure. Questions like, how do we collaborate more effectively? How do we become more effective interacting with others – especially those not like us or those who don’t share our points of view? Diversity of people equals diversity of thought. This is a good thing, right? Then… Read more »

Pathology Gets Personal: Reflections from USCAP 2017

Kate Clark & Kathy Morgan
June 20, 2017

Never has pathology felt more personal than after walking the halls of USCAP, the premier U.S. Anatomic Pathology conference, this past March. The case studies, the patient tissue specimens illuminated on 10 foot backdrops, the innovative company research scientists there in the flesh, the faces of those working so hard to improve patient care…wow. Pathology… Read more »

Digital e-Learning Programs: Instilling Confidence in Companion Diagnostic Results

Martha Townsend, Kate Clark & Kathy Morgan
March 24, 2017

The Anatomic Pathology lab has experienced monumental changes in recent years expanding the pathologist’s role beyond a cancer diagnosis to being a key contributor who delivers critical patient results defining treatment selection. The onslaught of genetic and molecular technologies and the increased availability of cancer targeted therapies has further added complexity to the pathologists’ role… Read more »

Leading Edge Advances in Genomics: Insights from AMP 2016

Martha Townsend & Kate Clark
January 5, 2017

Since its formation in 1995, the Association for Molecular Pathology (AMP) has been the premier showcase for remarkable technological advancements in the field of molecular diagnostics. The show has seen the evolution of nucleic acid testing from HIV viral load testing in 1996 to a CLIA waived PCR-based strep test in 2015 to the current… Read more »